[1] PERNA
L,WAHL H W,MONS U,et al. Cognitive impairment,all-cause and
cause-specific mortality among non-demented older adults[J]. Age ageing,2015,44(3):445-451.
[2] GBD
2021 Nervous System Disorders Collaborators. Global,regional,and national burden of disorders affecting the nervous system,1990—2021:a
systematic analysis for the global burden of disease study 2021[J]. Lancet
Neurol,2024,23(4):344-381.
[3] Alzheimer’s
Association. 2024 Alzheimer’s disease facts and figures[J]. Alzheimers Dement, 2024,20(5):3708-3821.
[4] SCHNEIDER
L S. Who’s dementia research priorities:a prescription
for failure?[J]. Lancet Neurol,2016,15(12):1202-1203.
[5] AKINYEMI
R O,MUKAETOVA-LADINSKA E B,ATTEMS
J,et al. Vascular risk factors and neurodegeneration in
ageing related dementias:Alzheimer’s disease and
vascular dementia[J]. Curr Alzheimer Res,2013,10(6):642-653.
[6] 中华医学会心血管病学分会高血压学组,中华心血管病杂志编辑委员会. 中国高血压患者血压血脂综合管理的专家共识[J]. 中华心血管病杂志,2021,49(6):554-563.
Hypertensive
Group of Chinese Society of Cardiology of Chinese Medical Association,Editorial Board of Chinese Journal of Cardiology. Expert consensus
on the comprehensive management of blood pressure and dyslipidemia in Chinese
hypertensive patients[J]. Chin J Cardiol,2021,49(6):554-563.
[7] BUYO
M,TAKAHASHI S,IWAHARA A,et al. Metabolic syndrome and cognitive function:cross-sectional study on community-dwelling non-demented older
adults in Japan[J]. J Nutr Health Aging,2020,24(8):878-882.
[8] KOUVARI
M,D’CUNHA N M,TRAVICA N,et al. Metabolic syndrome,cognitive
impairment and the role of diet:a narrative
review[J/OL]. Nutrients,2022,14(2):333[2024-04-01].
https://doi.org/10.3390/nu14020333.
[9] ZHOU
M Y,ZHANG J,JIA J K,et al. Association between hemoglobin A1c and asymptomatic carotid
intima-media thickness in middle-aged and elderly populations without
diabetes[J]. Nutr Metab Cardiovasc Dis,2022,32(6):1463-1469.
[10] WANG
L D,YIN L,HUA Y,et al. Fixed-dose combination treatment after stroke for secondary
prevention in China:a national community-based
study[J]. Stroke,2015,46(5):1295-1300.
[11] WANG
J,LIU Y F,ZHANG L,et al. Associations of high sensitivity C-reactive protein levels
with the prevalence of asymptomatic intracranial arterial stenosis[J]. Eur J
Neurol,2014,21(3):512-518.
[12] ONAT
A,HERGENC G,SARI I,et al. Dyslipidemic hypertension:distinctive
features and cardiovascular risk in a prospective population-based study[J]. Am
J Hypertens,2005,18(3):409-416.
[13] MCGRATH
E R,BEISER A S,DECARLI C,et al. Blood pressure from mid- to late life and risk of incident
dementia[J]. Neurology,2017,89(24):2447-2454.
[14] LITTLEJOHNS
T J,COLLISTER J A,LIU X,et al. Hypertension,a dementia polygenic
risk score,apoe genotype,and
incident dementia[J]. Alzheimers Dement,2023,19(2):467-476.
[15] BANGEN
K J,ARMSTRONG N M,AU R,et al. Metabolic syndrome and cognitive trajectories in the
Framingham offspring study[J]. J Alzheimers Dis,2019,71(3):931-943.
[16] ZHAO
Y,ZHANG H X,CHENG J,et al. Association between dyslipidaemia and cognitive impairment:a meta-analysis of cohort and case-control studies[J/OL]. J Integr
Neurosci,2024,23(2):40[2024-04-01].
https://doi.org/10.31083/j.jin2302040.
[17] GONG
J,HARRIS K,PETERS S A E,et al. Serum lipid traits and the risk of dementia:a cohort study of 254 575 women and 214 891 men in the UK biobank[J/OL]. EClinicalMedicine,2022,54:101695[2024-04-01].
https://doi.org/10.1016/j.eclinm.2022.101695.
[18] CHEN
H,DU Y,LIU S,et al. Association between serum cholesterol levels and Alzheimer’s
disease in China:a case-control study[J]. Int J Food
Sci Nutr,2019,70(4):405-411.
[19] HE
Q,LI Q,ZHAO J G,et al. Relationship between plasma lipids and mild cognitive
impairment in the elderly Chinese:a case-control
study[J/OL]. Lipids Health Dis,2016,15(1):146[2024-04-01].
https://doi.org/10.1186/s12944-016-0320-6.
[20] POWER
M C,RAWLINGS A,SHARRETT A R,et al. Association of midlife lipids with 20-year cognitive change:a cohort study[J]. Alzheimers Dement,2018,14(2):167-177.
|